Upgrade to SI Premium - Free Trial

Leerink Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform

October 5, 2026 7:59 AM
Leerink analyst David Risinger downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades